Method for producing viruses and vaccines in serum-free culture

{
  "publication_number": "US5753489A",
  "country": "US",
  "kind": "A",
  "title": "Method for producing viruses and vaccines in serum-free culture",
  "abstract": "A method for producing Influenza and other viruses and vaccines derived therefrom utilizes serum-free cultured vertebrate cells or vertebrate biomass aggregates to both eliminate the necessity to use costly methods requiring whole chicken embryos and, optionally, to provide proteases suitable for the activation of a wide variety of viruses. In one aspect, the method comprises the periodic or continuous removal of \"treatment portions\" of virus-containing culture medium into an \"augmentation loop\" for treatment with a broad range of substances, such as proteases that augment the activation of the virus. Use of the loop allows utilization of such substances at high concentrations while eliminating their cell toxic effects. Another aspect of the invention provides for the alteration of cleavage sites in virus proteins to thereby render them more susceptible to activation in culture. Thus, the method provides for the high yield production of many viruses that can be easily scaled up to continuous large scale production volumes and for resultant vaccines which are free of egg proteins and are much more economical to produce.",
  "claims": [
    "1. A method for producing virus antigens acceptable for human administration, comprising the steps of: (a) providing a culture of a continuous cell line of monkey kidney cells; (b) growing said cells for more than one generation in medium which is free of serum so that the cells can adapt to serum-free conditions; (c) infecting said culture of step (b) with a virus from the family Orthomyxoviridae; and (d) incubating said cell culture infected with said virus to propagate said virus into said medium to produce said virus antigens.",
    "2. The method according to claim 1, wherein during step b) said cells are grown in said medium for at least six generations.",
    "3. The method according to claim 1, wherein during step b) said cells are grown in said medium for at least twelve generations.",
    "4. The method according to claim 1, wherein during step b) said cells are grown in said medium for at least eighteen generations.",
    "5. The method according to claim 1, wherein during step b) said cells are grown in said medium for at least twenty-four generations.",
    "6. The method according to claim 1, wherein said cells are chosen from the group of cell lines consisting of VERO, CV-1, and LLC-MK2 cell lines.",
    "7. The method according to claim 1, wherein said virus is an Influenza virus.",
    "8. The method according to claim 6, wherein said cells are VERO cells."
  ],
  "description_excerpt": "The present application is a continuation-in-part of application Ser. No. 08/338,761, filed Nov. 10, 1994, now abandoned, entitled \"Method for Producing Influenza Virus and Vaccine.\" U.S. application Ser. No. 08/338,761 is incorporated herein by reference.\n\nThe present invention relates to means and methods for increasing the yield and efficiency of virus production in cell cultures and vaccines derived therefrom. The present invention also relates to means and methods for controlling the infectivity of viruses.\n\nEfficient vaccine production requires the growth of large quantities of virus produced in high yields from a host system. Different types of virus require different growth conditions in order to obtain acceptable yields. The host in which the virus is grown is therefore of great significance. Thus, depending upon the virus type, a virus may be grown in primary tissue culture cells, established cell lines or in embryonated eggs, such as those from chickens.\n\nThe cultivation conditions under which a virus strain is grown also are of great significance with respect to achieving an acceptably high yield of the strain. Thus, in order to maximize the yield of a desired virus strain, both the host system and the cultivation conditions must be adapted specifically to provide an environment that is advantageous for the production of a desired virus strain. Therefore, in order to achieve an acceptably high yield of different virus strains, a system which provides for easy and rapid adaptation of both the host system and the cultivation conditions is required.",
  "cpc": [
    "A61K 39/145",
    "A61K 2039/5252",
    "A61K 2039/55505",
    "A61K 39/00",
    "A61K 39/12",
    "A61K 39/245",
    "C07K 14/005",
    "C12N 2760/16122",
    "C12N 2760/16134",
    "C12N 2760/16151",
    "C12N 2760/16162",
    "C12N 2760/16163",
    "C12N 7/00"
  ],
  "ipc": [
    "A61K 39/145",
    "A61K 39/15",
    "A61K 39/245",
    "C07K 14/11",
    "C12N 7/00",
    "C12N 7/02"
  ],
  "assignees": [
    "Immuno AG"
  ],
  "inventors": [
    "Otfried Kistner",
    "Noel Barrett",
    "Wolfgang Mundt",
    "Friedrich Dorner"
  ],
  "filing_date": "1995-06-07",
  "publication_date": "1998-05-19",
  "grant_date": "1998-05-19",
  "priority_date": "1994-11-10",
  "application_number": "US-48704695-A",
  "family_id": "43501495",
  "cited_by_count": 133,
  "citations": [
    "US4072565A",
    "US4205131A",
    "EP0019218A2",
    "US4500513A",
    "US4525349A",
    "US5147790A",
    "EP0113665A2",
    "EP0115442A2",
    "US4664912A",
    "US4783411A",
    "US4927762A",
    "WO1991003552A1",
    "WO1991009937A1",
    "US5391491A",
    "US5316938A",
    "EP0485689A1",
    "US5393668A"
  ]
}